Dario Amodei says AI's problem is a crisis of trust that marketing cannot fix

Anthropic’s CEO says the cancer line no longer works. In his words: “at this point, saying that AI will cure cancer is more a cliche than it is inspiring, and most people think it is deceptive.”

What Amodei wrote

Dario Amodei posted the argument on X on August 15, 2026, as a two-part reply to investor Gavin Baker, opening with the note that he does not usually spend time on social media. As of this writing it is still his most recent post.

His diagnosis is that the public’s problem with AI is “fundamentally a crisis of trust.” People, he wrote, “don’t trust companies, governments, or the tech industry and always suspect that we are cooking up some new way to screw them over.” A glitzy marketing campaign, which he says some have advocated Anthropic run, will not change that. His own answer to what would: “The thing that will work is actually curing cancer.”

He also named the criticism he considers fair. AI companies, including his own, have not yet delivered on their big promises, and he called that “totally on us.” Anthropic says it is ramping up its biology and medicine work and expects results in the coming years.

Why it matters that the vendor is saying it

The industry’s usual response to public skepticism has been better storytelling: more demos, more promises, a bigger campaign. Amodei is arguing that the story itself has become the liability. After three years of promised breakthroughs, a promise is now worth less than a result, and repeating the promise louder makes the deficit more visible, not less.

The numbers behind his concern are not flattering. Pew found that half of US adults are more concerned than excited about AI in daily life, against 10 percent who are more excited. When Pew first asked in 2021, the concerned share was 37 percent. Trust has moved in the wrong direction over the exact period in which the technology improved fastest.

What to watch

The test Amodei has set for his own company is unusually concrete: a cure, or at least a documented medical result, rather than a message. Anthropic’s stated timeline is “the coming years,” which is vague enough to be safe and specific enough to be checked against. The open question is whether a lab that has just said marketing will not work can resist the pressure to market anyway. For now, the most senior voice at one of the frontier labs has put the burden where critics have long wanted it: on delivery.